D&O Disclosure
Ordinary Shares
Ongoing Disclosure Notice
Disclosure of Directors and Senior Managers Relevant Interests
Sections 297(2) and 298(2), Financial Markets Conduct Act 2013
Director or senior manager giving disclosure
Summary of acquisition or disposal of relevant interest (excluding specified derivatives)
Registered Holder and Beneficial owner
23,244
9,244
Dewald Edward Janse van Rensburg
Dewald Edward Janse van Rensburg
Summary of acquisition or disposal of specified derivatives relevant interest (if applicable)
Details of affected derivative-
For that derivative,-
Details of transactions giving rise to acquisition or disposal
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
N/A
Class of affected quoted financial products:
Nature of the affected relevant interest(s):
For that relevant interest-
Number held in class before acquisition or disposal:
Number held in class after acquisition or disposal:
Current registered holder(s):
Registered holder(s) once transfers are registered:
To NZX Limited; and
Name of listed issuer:
Date this disclosure made:
Date of last disclosure:
Trade Window Holdings Limited
20/12/2024
18/12/2024
Full name(s):
Name of listed issuer:
Name of related body corporate (if applicable):
Position held in listed issuer:
Dewald Edward Janse van Rensburg
Trade Window Holdings Limited
N/A
Senior Manager
Type of affected derivative:
Class of underlying financial products:
N/A
N/A
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative(if any):
The price specified in the terms of the derivative (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
N/A
N/A
N/A
N/A
N/A
N/A
Total number of transactions to which notice relates:
2
N/A
N/A
N/A
20/12/2024
N/A
18 & 20 December 2024
Sale of Shares
N/A
$2,800
14.000
Ordinary Shares in TWL
Ordinary Shares
Beneficial Owner
9,244
Dewald Edward Janse van Rensburg
Details of transactions requiring disclosure-
Date of transaction:
Nature of transaction:
Name of any other party or parties to the transaction (if known):
The consideration, expressed in New Zealand dollars, paid or received for the
acquisition or disposal. If the consideration was not in cash and cannot be readily by
converted into a cash value, describe the consideration:
Number of financial products to which the transaction related:
If the issuer has a financial products trading policy that prohibits directors or senior
managers from trading during any period without written clearance (a closed period)
include the following details—
Whether relevant interests were acquired or disposed of during a closed period:
Whether prior written clearance was provided to allow the acquisition or disposal to
proceed during the closed period:
Date of the prior written clearance (if any):
Summary of other relevant interests after acquisition or disposal:
Class of quoted financial products:
Nature of relevant interest:
For that relevant interest,-
Number held in class:
Current registered holder(s):
For a derivative relevant interest,-
Type of derivative:
Certification
I, certify that, to the best of my knowledge and belief, the information contained in this
disclosure is correct and that I am duly authorised to make this disclosure by all
persons for whom it is made.
Signature of director or officer:
Date of signature:
or
Signature of person authorised to sign on behalf of director or officer:
Date of signature:
Name and title of authorised person:
Details of derivative,-
The notional value of the derivative (if any) or the notional amount of underlying
financial products (if any):
A statement as to whether the derivative is cash settled or physically settled:
Maturity date of the derivative (if any):
Expiry date of the derivative (if any):
The price's specified terms (if any):
Any other details needed to understand how the amount of the consideration payable
under the derivative or the value of the derivative is affected by the value of the
underlying financial products:
For that derivative relevant interest,-
Parties to the derivative:
If the director or senior manager is not a party to the derivative, the nature of the
relevant interest in the derivative:
N/A
N/A
N/A
N/A
N/A
N/A
N/A
N/A
Data sourced from publicly available filings. Our datasets may not be complete. Automated analysis can produce errors. If you believe any data on this page is incorrect, please contact us at hello@nzxplorer.co.nz. For informational purposes only. Not investment advice.
Other issuers discussed similar conditions around this time
Matched by meaning across NZX announcement text, not keywords — based on our semantic index of announcement bodies.
- TAH — Third Age Health Services Limited: D&O Ongoing Disclosure – Bevan John Walsh2025-01-17
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Third Age Health Services Limited Date this disclosure made: 17 January 2025 Date…”
- TAH — Third Age Health Services Limited: D&O Ongoing Disclosure – Bevan John Walsh2025-01-23
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Third Age Health Services Limited Date this disclosure made: 24 January 2025 Date…”
- TAH — Third Age Health Services Limited: D&O Ongoing Disclosure – Bevan John Walsh2025-01-28
“Ongoing Disclosure Notice Disclosure of Directors and Senior Managers Relevant Interests Sections 297(2) and 298(2), Financial Markets Conduct Act 2013 To NZX Limited; and Name of listed issuer: Third Age Health Services Limited Date this disclosure made: 29 January 2025 Date…”